Abstract
The interaction of antigen-presenting cells with free peptides or a denatured protein can give rise to peptide–MHC class II complexes that are distinct from those generated after the processing of the whole protein. Such atypical peptide–MHC complexes can be recognized by unconventional 'type B' T cells that are not a component of the normal immune response to proteins. Importantly, these unconventional T cells can be found in the setting of autoimmunity. Here, we discuss unconventional peptide recognition by type B T cells and consider the implications for type 1 diabetes and other autoimmune diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Neefjes, J., Jongsma, M. L., Paul, P. & Bakke, O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nature Rev. Immunol. 11, 823–836 (2011).
Lovitch, S. B. & Unanue, E. R. Conformational isomers of a peptide–class II MHC complex. Immunol. Rev. 207, 293–313 (2005).
van den Hoorn, T., Paul, P., Jongsma, M. L. & Neefjes, J. Routes to manipulate MHC class II antigen presentation. Curr. Opin. Immunol. 23, 88–95 (2011).
Roche, P. A. & Cresswell, P. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 345, 615–618 (1990).
Neefjes, J. J., Stollorz, V., Peters, P. J., Geuze, H. J. & Ploegh, H. L. The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell 61, 171–183 (1990).
Sloan, V. S. et al. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375, 802–806 (1995).
Viner, N. J., Nelson, C. A. & Unanue, E. R. Identification of a major I-Ek-restricted determinant of hen egg lysozyme: limitations of lymph node proliferation studies in defining immunodominance and crypticity. Proc. Natl Acad. Sci. USA 92, 2214–2218 (1995).
Viner, N. J., Nelson, C. A., Deck, B. & Unanue, E. R. Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing. J. Immunol. 156, 2365–2368 (1996).
Pu, Z., Carrero, J. A. & Unanue, E. R. Distinct recognition by two subsets of T cells of an MHC class II–peptide complex. Proc. Natl Acad. Sci. USA 99, 8844–8849 (2002).
Mohan, J. F. et al. Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes. Nature Immunol. 11, 350–354 (2010).
Mohan, J. F., Petzold, S. J. & Unanue, E. R. Register shifting of an autoimmune insulin peptide–MHC II complex allows for the escape of diabetogenic T cells from negative selection. J. Exp. Med. 208, 2375–2383 (2011).
Sercarz, E. E. et al. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11, 729–766 (1993).
Gammon, G. & Sercarz, E. How some T cells escape tolerance induction. Nature 342, 183–185 (1989).
Cibotti, R. et al. Tolerance to self-protein involves its immunodominant but does not involve its subdominant determinants. Proc. Natl Acad. Sci. USA 89, 416–420 (1992).
Cabaniols, J. P., Cibotti, R., Kourilsky, P., Kosmatopoulos, K. & Kanellopoulos, J. M. Dose-dependent T cell tolerance to an immunodominant self peptide. Eur. J. Immunol. 24, 1743–1749 (1994).
Fairchild, P. J., Pope, H. & Wraith, D. C. The nature of cryptic epitopes within the self-antigen myelin basic protein. Int. Immunol. 8, 1035–1043 (1995).
Pu, Z., Lovitch, S. B., Bikoff, E. K. & Unanue, E. R. T cells distinguish MHC–peptide complexes formed in separate vesicles and edited by H2-DM. Immunity 20, 467–476 (2004).
Peterson, D. A., DiPaolo, R. J., Kanagawa, O. & Unanue, E. R. Quantitative analysis of the T cell repertoire that escapes negative selection. Immunity 11, 453–462 (1999).
Barlow, A. K., He, X. & Janeway, C. Jr. Exogenously provided peptides of a self-antigen can be processed into forms that are recognized by self-T cells. J. Exp. Med. 187, 1403–1415 (1998).
Gyotoku, T., Fukui, Y. & Sasazuki, T. An endogenously processed self peptide and the corresponding exogenous peptide bound to the same MHC class II molecule could be distinct ligands for TCR and different kinetic stability. Eur. J. Immunol. 28, 4050–4061 (1998).
Lovitch, S. B., Walters, J. J., Gross, M. L. & Unanue, E. R. Antigen presenting cells present Abk-derived peptides which are autoantigenic to type B T cells. J. Immunol. 170, 4155–4160 (2003).
Wegmann, D. R. & Eisenbarth, G. S. It's insulin. J. Autoimmun. 15, 286–291 (2000).
Wegmann, D. R., Norbury-Glaser, M. & Daniel, D. Insulin-specific T cells are a predominant component of islet infiltrates in prediabetic NOD mice. Eur. J. Immunol. 24, 1853–1857 (1994).
Daniel, D., Gill, R. G., Schloot, N. & Wegmann, D. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T-cell clones isolated from NOD mice. Eur. J. Immunol. 25, 1056–1062 (1995).
Jaeckel, E., Lipes, M. A. & von Boehmer, H. Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes. Nature Immunol. 5, 1028–1035 (2004).
French, M. B. et al. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes 46, 34–39 (1997).
Chentoufi, A. A. & Polychronakos, C. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 51, 1383–1390 (2002).
Nakayama, M. et al. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435, 220–223 (2005).
Hausmann, D. H., Yu, B., Hausmann, S. & Wucherpfennig, K. W. pH-dependent peptide binding properties of the type 1 diabetes-associated I-Ag7 molecule: rapid release of CLIP at an endosomal pH. J. Exp. Med. 189, 1723–1734 (1999).
Halbout, P., Briand, J. P., Becourt, C., Muller, S. & Boitart, C. T cell response to preproinsulin I and II in the nonobese diabetic mouse. J. Immunol. 169, 2436–2443 (2002).
Levisetti, M. G., Suri, A., Petzold, S. J. & Unanue, E. R. The insulin-specific T cells of nonobese diabetic mice recognize a weak MHC-binding segment in more than one form. J. Immunol. 178, 6051–6057 (2007).
Pugliese, A. et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nature Genet. 15, 293–297 (1997).
Kawamura, K., McLaughlin, K. A., Weissert, R. & Forsthuber, T. G. Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice. J. Immunol. 181, 3202–3211 (2008).
Lehmann, P. V., Forsthuber, T., Miller, A. & Sercarz, E. E. Spreading of T-cell autoimmunity to cryptic determinants of an auto-antigen. Nature 358, 155–157 (1992).
Huang, J. C. et al. T cell recognition of distinct peptide: I-Au conformers in murine experimental autoimmune encephalomyelitis. J. Immunol. 171, 2467–2477 (2003).
Sweenie, C. H., Mackenzie, K. J., Rone-Orugboh, A., Liu, M. & Anderton, S. M. Distinct T cell recognition of naturally processed and cryptic epitopes with the immunodominant 35–55 region of myelin oligodendrocyte glycoprotein. J. Neuroimmunol. 183, 7–16 (2007).
Bellone, M., Ostlie, N., Karachunski, P., Manfredi, A. A. & Conti-Troncoli, B. M. Cryptic epitopes on the nicotinic acetylcholine receptor are recognized by autoreactive CD4+ cells. J. Immunol. 151, 1025–1038 (1993).
Matsuo, H. et al. Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor. J. Immunol. 155, 3683–3692 (1995).
Markovic-Plese, S. et al. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J. Immunol. 155, 982–992 (1995).
Semana, G., Gausling, R., Jackson, R. A. & Hafler, D. A. T cell autoreactivity to proinsulin epitopes in diabetic patients and healthy subjects. J. Autoimmun. 12, 259–267 (1999).
Denzin, L. K., Hammond, C. & Cresswell, P. HLA-DM interactions with intermediates in HLA-DR maturations and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 184, 2153–2165 (1996).
Zarutskie, J. A. et al. The kinetic basis of peptide exchange catalysis by HLA-DM. Proc. Natl Acad. Sci. USA 98, 12450–12455 (2001).
Sant, A. J. et al. The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes. Immunol. Rev. 207, 261–278 (2005).
Schmitt, L., Boniface, J. J., Davis, M. M. & McConnell, H. M. Kinetic isomers of a class II MHC–peptide complex. Biochemistry 37, 17371–17380 (1998).
Schmitt, L., Kratz, J. R., Davis, M. M. & McConnell, H. M. Catalysis of peptide dissociation from class II MHC–peptide complexes. Proc. Natl Acad. Sci. USA 96, 6581–6586 (1999).
Kasson, P. M., Rabinowitz, J. D., Schmitt, L., Davis, M. M. & McConnell, H. M. Kinetics of peptide binding to the class II MHC protein I-Ek. Biochemistry 39, 1048–1058 (2000).
Belmares, M. P., Busch, R., Mellins, E. D. & McConnell, H. M. Formation of two peptide/MHC II isomers is catalyzed differentially by HLA-DM. Biochemistry 42, 838–847 (2003).
Schmitt, L., Boniface, J. J., Davis, M. M. & McConnell, H. M. Conformational isomers of a class II MHC–peptide complex in solution. J. Mol. Biol. 286, 207–218 (1999).
Lindner, R. & Unanue, E. R. Distinct antigen MHC class II complexes generated by separate processing pathways. EMBO J. 15, 6910–6920 (1996).
Lovitch, S. B., Pu, Z. & Unanue, E. R. Amino-terminal flanking residues determine the conformation of a peptide–class II MHC complex. J. Immunol. 176, 2958–2968 (2006).
Bankovich, A. J., Girvin, A. T., Moesta, A. K. & Garcia, K. C. Peptide register shifting within the MHC groove: theory becomes reality. Mol. Immunol. 40, 1033–1039 (2004).
Scott, A., Peterson, P. A., Teyton, L. & Wilson, I. A. Crystal structures of two I-Ad–peptide complexes reveal that high affinity can be achieved without large anchor residues. Immunity 8, 319–329 (1998).
McFarland, B. J., Sant, A. J., Lybrand, T. P. & Beeson, C. Ovalbumin (323–339) peptide binds to the major histocompatibility complex class II I-Ad protein using two functionally distinct registers. Biochemistry 38, 1663–1667 (1999).
Robertson, J. M., Jensen, P. E. & Evavold, B. D. DO11.10 and OT-11 T cells recognize a C-terminal ovalbumin 323–339 epitope. J. Immunol. 164, 4706–4712 (2000).
Landais, E. et al. New design of MHC class II tetramers to accommodate fundamental principles of antigen presentation. J. Immunol. 183, 7949–7957 (2009).
Anderton, S. M., Viner, N. J., Matharu, P., Lowrey, P. A. & Wraith, D. C. Influence of a dominant cryptic epitope on autoimmune T cell tolerance. Nature Immunol. 3, 175–181 (2002).
Seamons, A. et al. Competition between two MHC binding registers in a single peptide processed from myelin basic protein influences tolerance and susceptibility to autoimmunity. J. Exp. Med. 197, 1391–1397 (2003).
Harrington, C. J. et al. Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein. Immunity 8, 571–580 (1998).
Stadinski, B. D. et al. Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register. Proc. Natl Acad. Sci. USA 107, 10978–10983 (2010).
Wong, F. S. et al. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nature Med. 5, 1026–1031 (1999).
Clement, C. C. et al. An expanded self-antigen peptidome is carried by the human lymph as compared to the plasma. PLoS ONE 5, e9863 (2010).
Théry, C. et al. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 166, 7309–7318 (2001).
Chaput, N. et al. Dendritic cell-derived exosomes: biology and clinical implementations. J. Leukoc. Biol. 80, 471–478 (2006).
Calderon, B., Suri, A., Miller, M. J. & Unanue, E. R. Dendritic cells in islets of Langerhans constitutively present β cell derived peptides bound to their class II MHC molecules. Proc. Natl Acad. Sci. USA 105, 6121–6126 (2008).
Calderon, B. & Unanue, E. R. Antigen presentation events in autoimmune diabetes. Curr. Opin. Immunol. 24, 1–10 (2011).
Croizet, K., Rabilloud, R., Kostrouch, Z., Nicolas, J. F. & Rousset, B. Culture of dendritic cells from a nonlymphoid organ, the thyroid gland: evidence for TNF-α-dependent phenotypic changes of thyroid-derived dendritic cells. Lab. Invest. 80, 1215–1225 (2000).
Klein, J. R. & Wang, H. C. Characterization of a novel set of resident intrathyroidal bone marrow-derived hematopoietic cells: potential for immune-endocrine interactions in thyroid homeostasis. J. Exp. Biol. 207, 55–65 (2004).
Verginis, P., Stanford, M. M. & Carayanniotis, G. Delineation of five thyroglobulin T cell epitopes with pathogenic potential in experimental autoimmune thyroiditis. J. Immunol. 169, 5332–5337 (2002).
Fairchild, P. J., Wildgoose, R., Atherton, E., Webb, S. & Wraith, D. C. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int. Immunol. 5, 1151–1158 (1993).
Anderton, S. M. Post-translational modifications of self antigens: implications for autoimmunity. Curr. Opin. Immunol. 16, 753–758 (2004).
Acknowledgements
We are grateful to our many colleagues who contributed to the work cited here. They include B. Calderon, J. Carrero, K. Chang, M. Gross, J. Herzog, M. Levisetti, S. Lovitch, M. Miller, S. Petzold, Z. Pu and B. Strong. Our work was supported by grants from the US National Institutes of Health, the Juvenile Diabetes Research Foundation and the Kilo Diabetes and Vascular Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
Rights and permissions
About this article
Cite this article
Mohan, J., Unanue, E. Unconventional recognition of peptides by T cells and the implications for autoimmunity. Nat Rev Immunol 12, 721–728 (2012). https://doi.org/10.1038/nri3294
Published:
Issue Date:
DOI: https://doi.org/10.1038/nri3294
This article is cited by
-
CD4+ T cells in cancer
Nature Cancer (2023)
-
The MHC-II peptidome of pancreatic islets identifies key features of autoimmune peptides
Nature Immunology (2020)
-
Structure-based selection of human metabolite binding P4 pocket of DRB1*15:01 and DRB1*15:03, with implications for multiple sclerosis
Genes & Immunity (2019)
-
Scouting for Naturally Low-Toxicity Wheat Genotypes by a Multidisciplinary Approach
Scientific Reports (2019)
-
Class II MHC antigen processing in immune tolerance and inflammation
Immunogenetics (2019)